Astrana Health, Inc. - Common Stock (ASTH)

CUSIP: 03763A207

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+737,900
SEC-reported price per share
$46.41
Number of holders
71
Value change
+$36,239,998
Number of buys
45
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
49,605,599

Security key

03763A207

Report period

Q2 2026

Institutions

71

Top holders

10

Ownership snapshot

Top reported holders of ASTH - Astrana Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
ALLIED PHYSICIANS OF CALI...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 12% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 12%
ALLIED PHYSICIANS OF CALIFORNIA, ... 11%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.3%
Thomas S. Lam 16%
Kenneth T. Sim 16%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
12%
$191,646,870
6,234,446 shares
-$6,109,882 31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp
3/4/5 13D/G
10%+ Owner · Allied Physicians of California, a Professional Medical Corporation
11%
from 13D/G
$232,801,164
6,132,802 shares
15 Feb 2025
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
5.3%
$126,195,454
2,648,939 shares
$0 30 Jun 2026
Thomas S. Lam
3/4/5
Director
16%
$189,593,458
7,732,165 shares
06 Apr 2026
Kenneth T. Sim
3/4/5
Executive Chairman, Director
16%
$188,614,541
7,692,242 shares
06 Apr 2026
Brandon Sim
3/4/5
CEO and President
3.8%
$46,512,771
1,896,932 shares
27 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
71
Shares
11,398,419
Rows available
71
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
170
Q2 2026 holders
71
Holder diff
-99
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .